Search Results

You are looking at 81 - 90 of 106 items for :

  • "Bladder cancer" x
  • All content x
Clear All
Full access

Anya Litvak, Andrea Cercek, Neil Segal, Diane Reidy-Lagunes, Zsofia K. Stadler, Rona D. Yaeger, Nancy E. Kemeny, Martin R. Weiser, Melissa S. Pessin, and Leonard Saltz

, 12 patients developed lung cancer, 6 developed prostate cancer, 5 developed breast cancer, 5 developed a noncolorectal gastrointestinal malignancy, 3 developed bladder cancer, 2 developed thyroid cancer, 1 developed thymic cancer, and 1 developed

Full access

Alexander P. Cole, Chang Lu, Marieke J. Krimphove, Julie Szymaniak, Maxine Sun, Sean A. Fletcher, Stuart R. Lipsitz, Brandon A. Mahal, Paul L. Nguyen, Toni K. Choueiri, Adam S. Kibel, Adil H. Haider, and Quoc-Dien Trinh

, . Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival? Cancer 2019 ; 125 : 1319 – 1329 . 10.1002/cncr.31926 30633323 18. Krimphove MJ , Cole AP , Fletcher SA

Full access

Arti Hurria, Ilene S. Browner, Harvey Jay Cohen, Crystal S. Denlinger, Mollie deShazo, Martine Extermann, Apar Kishor P. Ganti, Jimmie C. Holland, Holly M. Holmes, Mohana B. Karlekar, Nancy L. Keating, June McKoy, Bruno C. Medeiros, Ewa Mrozek, Tracey O’Connor, Stephen H. Petersdorf, Hope S. Rugo, Rebecca A. Silliman, William P. Tew, Louise C. Walter, Alva B. Weir III, and Tanya Wildes

Guidelines for AML in centers skilled in the management and supportive care of AML (to view the most recent version of these guidelines, visit the NCCN Web site at www.NCCN.org ). Bladder Cancer: Intravesical immunotherapy with Bacillus Calmette

Full access

Michael Xiang and Elizabeth A. Kidd

, Shipley WU , . Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233 . J

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Don Dizon, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Jeffrey Peppercorn, Muhammad Raza, M. Alma Rodriguez, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian, and Deborah A. Freedman-Cass

. Wyszynski A Tanyos SA Rees JR . Body mass and smoking are modifiable risk factors for recurrent bladder cancer . Cancer 2014 ; 120 : 408 – 414 . 7. Hudis CA Jones L . Promoting exercise after a cancer diagnosis: easier said than done . Br J

Full access

Vivek Verma, Pamela K. Allen, Charles B. Simone II, Hiram A. Gay, and Steven H. Lin

in glioblastoma . J Neurooncol 2017 ; 135 : 173 – 181 . 35. Haque W Verma V Butler EB Teh BS . Radical cystectomy versus chemoradiation for musle-invasive bladder cancer: impact of treatment facility and sociodemographics . Anticancer

Full access

Vivek Verma, Amy C. Moreno, Waqar Haque, Penny Fang, and Steven H. Lin

: 146 – 154 . 24. Haque W Verma V Butler EB Teh BS . Radical cystectomy versus chemoradiation for muscle-invasive bladder cancer: impact of treatment facility and sociodemographics . Anticancer Res 2017 ; 37 : 5603 – 5608 . 25

Full access

Christopher M. Booth, Sulaiman Nanji, Xuejiao Wei, Yingwei Peng, James J. Biagi, Timothy P. Hanna, Monika K. Krzyzanowska, and William J. Mackillop

-invasive bladder cancer: a population-based outcomes study . Cancer 2014 ; 120 : 1630 – 1638 . 11. Meyer RM . Generalizing the results of cancer clinical trials . J Clin Oncol 2010 ; 28 : 187 – 189 . 12. Booth CM Mackillop WJ

Full access

Peter G. Shields, Roy S. Herbst, Douglas Arenberg, Neal L. Benowitz, Laura Bierut, Julie Bylund Luckart, Paul Cinciripini, Bradley Collins, Sean David, James Davis, Brian Hitsman, Andrew Hyland, Margaret Lang, Scott Leischow, Elyse R. Park, W. Thomas Purcell, Jill Selzle, Andrea Silber, Sharon Spencer, Tawee Tanvetyanon, Brian Tiep, Hilary A. Tindle, Reginald Tucker-Seeley, James Urbanic, Monica Webb Hooper, Benny Weksler, C. Will Whitlock, Douglas E. Wood, Jennifer Burns, and Jillian Scavone

bladder cancer patients treated with radical cystectomy . Eur Urol 2013 ; 64 : 456 – 464 . 41. Ehdaie B Furberg H Zabor EC . Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma . BJU Int

Full access

Emily J. Guerard, Allison M. Deal, YunKyung Chang, Grant R. Williams, Kirsten A. Nyrop, Mackenzi Pergolotti, Hyman B. Muss, Hanna K. Sanoff, and Jennifer L. Lund

study . Crit Rev Oncol Hematol 2010 ; 76 : 208 – 217 . 33. Chappidi MR Kates M Patel HD . Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy . Urol Oncol 2016 ; 34 : 256.e1 – 6